PureTech Health PLC Presenting at Cowen and Company Conference

TIDMPRTC

PureTech Health PLC

23 February 2016

PureTech Health plc

PureTech to present at the Cowen and Company 36th Annual Health Care Conference

Boston, Massachusetts, February 23, 2016 - PureTech Health plc ("PureTech" or the "Company", LSE: PRTC), a cross-disciplinary healthcare company developing novel medicines to tackle fundamental healthcare needs in disruptive ways, today announces that Daphne Zohar, PureTech's Chief Executive Officer, will be presenting at the Cowen and Company 36th Annual Health Care Conference in Boston, MA, being held on March 7-9, 2016.

PureTech's presentation is scheduled for Monday 7 March 2016 at 4:40-5:10pm ET and will be followed by a breakout session from 5:15-5:45pm ET.

About PureTech Health

PureTech Health (PureTech Health plc, PRTC.L) is a cross-disciplinary healthcare company, developing innovative products that could improve the lives of billions of patients. PureTech has a pipeline of 12 operating companies, seven of which are "growth stage" with external validation including strategic partnerships, outside funding, proof-of-concept or peer review in prestigious scientific journals. PureTech also has a pipeline of ten "concept phase" initiatives resulting from review of more than 650 ideas annually. PureTech is focused on areas including immune and inflammatory disorders; cognitive and psychiatric disorders; diabetes and obesity; oncology; and infectious diseases, and has over 110 patents and patent applications. PureTech's leading team and board, along with an advisory network of more than 50 expert founder-scientists and advisors across multiple disciplines, gives PureTech access to potentially ground-breaking science and technological innovation. For more information, visit www.puretechhealth.com and connect with us on Twitter.

# # #

Enquiries:

 
 PureTech 
  Stephen Muniz, Executive Vice President,    +1 617 456 
  Legal and Operations                         0042 
 FTI Consulting (Communications adviser 
  to PureTech) 
  Ben Atwell                                  +44 (0) 20 
  Matthew Cole                                 3727 1000

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRAUUVBRNKAUUAR

(END) Dow Jones Newswires

February 23, 2016 04:00 ET (09:00 GMT)

Puretech Health (LSE:PRTC)
Historical Stock Chart
From Jun 2024 to Jul 2024